Trending News

OCC Issues Bulletins on Customer Financial Record Protections and Politicized Debanking

Homebuyers Privacy Protection Act Signed Into Law, Restricting Trigger Leads

E-Verify Update: New Guidance for Employers on EAD Revocations

Responses to DOD Survey on Alternatives to TSCA High Priority Chemicals Due September 26, 2025

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Labviva Announces Key Executive Appointments to Drive Global Expansion
Posted On Tuesday, June 17, 2025
NodThera Announces Appointment of Elisabeth Björk as Board Member
Posted On Tuesday, June 17, 2025
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
Posted On Tuesday, June 17, 2025
Llusern Scientific Announces ISO 13485 Certification for its Point-of-Care Diagnostics System for Urinary Tract Infections
Posted On Tuesday, June 17, 2025
Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
Posted On Monday, June 16, 2025
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
Posted On Monday, June 16, 2025
BioAro Launches PanOmiQ™ Research in Breakthrough for AI-Driven Drug Discovery and Multi-Omics
Posted On Monday, June 16, 2025
Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year
Posted On Monday, June 16, 2025
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
Posted On Monday, June 16, 2025
INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025
Posted On Monday, June 16, 2025
3Daughters to Lead Panel at BIO International Convention on Patient Reported Outcomes that Includes FDA Division Director
Posted On Monday, June 16, 2025
Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development Program
Posted On Monday, June 16, 2025
Actuate Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
Posted On Monday, June 16, 2025
Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer
Posted On Monday, June 16, 2025
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
Posted On Monday, June 16, 2025
Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy
Posted On Monday, June 16, 2025
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
Posted On Monday, June 16, 2025
Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study
Posted On Monday, June 16, 2025
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity
Posted On Monday, June 16, 2025
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025
Posted On Monday, June 16, 2025
Milestone Pharmaceuticals Submits Response to the FDA’s CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting
Posted On Monday, June 16, 2025
X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
Posted On Monday, June 16, 2025
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
Posted On Monday, June 16, 2025
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
Posted On Monday, June 16, 2025
FOXO TECHNOLOGIES INC. CREATES ACQUISITION VEHICLE AND APPOINTS NEW INTERIM CFO
Posted On Monday, June 16, 2025

Print